Omole T, Weinberg AS, Azizad M, Greenberg D, et al. A phase 3 randomized, double-blind clinical study to evaluate the safety and immunogenicity of V116 when administered concomitantly with influenza vaccine in adults 50 years of age or older. Vaccine 2025;62:127514.
PMID: 40714528